DY
Dyadic International, Inc.
DYAI · NASDAQ
$0.52 -2.77% (-$0.01)
1M -47.74%
Market Cap $19.0M
P/E Ratio -
Div. Yield -
ROE 2,918.10%
Piotroski F-Score Weak
3/9Valuation
30 /100
Expensive P/S 5.46x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 25.08%
Book val. growth 51.92%
EPS growth N/A
Profitability
11 /100
Weak Gross margin 30.44%
Net margin 219.50%
Op. margin 213.59%
Quality
7 /100
Poor ROIC 278.95%
ROE 2,918.10%
ROA 116.60%
Debt
36 /100
Moderate Current ratio 1.65x
Int. coverage -17.20x
Debt/Equity N/A
Stability
42 /100
Moderate Beta 1.15x
Rev. volatility 44.35%
EPS volatility 22.87%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre DYAI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Emalfarb
Employees
5
Headquarters
Jupiter
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report